iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER All Issues Volume 3 Issue 3
Volume 3 Issue 3, September 2024
Cover
Back cover
Cover
Back cover
Contents(PDF)
10 articles
Previous Issue
|
Next Issue
Editorial | Open Access
Systematic treatment in unresectable hepatocellular carcinoma: The most concerns
Jian-Hong Zhong, Kang Chen, Ze Su, [...], Shao-Ping Liu, Fan-Jian Zeng, Lin Ye, the GUIDANCE investigators << Fewer
Published: 13 August 2024
2024, 3(3): 100112
Editorial | Open Access
Transarterial chemoembolization plus radiofrequency ablation: One of the effective interventions for hepatocellular carcinoma
Yong Xie, Jian Wang, Yinghua Zou
Published: 26 August 2024
2024, 3(3): 100114
Original Article | Open Access
Short-term effects of modified ultrasonography in laparoscopic anatomical hepatectomy for hepatocellular carcinoma
Xun Wang, Xuan Meng, Liming Wang, [...], Peng Wang, Zhihao Wang, Weiqi Rong, Zhiyu Lu, Hongguang Wang << Fewer
Published: 05 July 2024
2024, 3(3): 100106
Original Article | Open Access
Serum IP-10 increase correlated with PEG-IFNα response in nucleot(s)ide analogs-treated patients with chronic hepatitis B
Wen-Xin Wang, Xiaoyan Li, Xue-Yuan Jin, [...], Rui Jia, Hong-Min Wang, Shuang-Nan Zhou, Xin Zhang, Ying-Ying Gao, Fu-Sheng Wang, Junliang Fu << Fewer
Published: 29 July 2024
2024, 3(3): 100107
Original Article | Open Access
Tumor burden score and alpha-fetoprotein level predict prognosis of patients with unresectable hepatocellular carcinoma treated with tyrosine kinase inhibitor and anti-PD-1 antibody
Shichuan Tang, Tingfeng Huang, Cong Luo, [...], Jun Fu, Kailing Zhang, Qingjing Chen, Jie Kong, Jianxi Zhang, Zhenghong Sun, Yongkang Diao, Kongying Lin, Yongyi Zeng << Fewer
Published: 08 August 2024
2024, 3(3): 100109
Original Article | Open Access
Targeting hepatocellular carcinoma growth and metabolism: A synergistic approach with para-toluenesulfonamide and radiofrequency ablation
Na Liu, Jianzeng Zhang, Jiaojiao Wu, [...], Fan Feng, Yantao Chai, Yongwu Li, Bo Liu << Fewer
Published: 12 August 2024
2024, 3(3): 100111
Original Article | Open Access
Network pharmacology and single-cell transcriptomic analysis with molecular docking to elucidate the potential compounds and targets of Polygonum cuspidatum Sieb.et Zucc. for hepatocellular carcinoma
Wenze Wu, Yuzhu Shi, Yongzi Wu, [...], Rui Zhang, Xinyan Wu, Weidi Zhao, Zhiyuan Chen, Gang Ye << Fewer
Published: 22 August 2024
2024, 3(3): 100115
Commentary | Open Access
Genetic research on MASLD: New insights into cardiovascular disease and cancer risk
Ming Yang, Juan Liu
Published: 10 August 2024
2024, 3(3): 100108
Commentary | Open Access
Optimising postoperative surveillance for hepatocellular carcinoma: Beyond histological predictors
Jiahao Xu, Lihui Gu, Tian Yang
Published: 11 August 2024
2024, 3(3): 100110
Commentary | Open Access
Unraveling the epidemiology of metabolic dysfunction-associated liver cancer: Insights from mixed etiologies, regional variations, and gender disparities
Gong Feng, Ya-Fei Fan, Ru-Xin Li, [...], Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng << Fewer
Published: 14 August 2024
2024, 3(3): 100113